
---
title: '强生或诱发自身免疫性疾病 美国FDA拟发新警告'
categories: 
 - 新媒体
 - 快媒体
 - 首页更新
headimg: 'https://www.kuai.media/news/2021/07/13/static/image/kuai/external-link.gif'
author: 快媒体
comments: false
date: 2021-07-13 03:08:38
thumbnail: 'https://www.kuai.media/news/2021/07/13/static/image/kuai/external-link.gif'
---

<div>   
<a href="https://www.kuai.media/go.php?aid=238516" target="_blank" role="link" data-focusable="true" class="sum" rel=" noopener noreferrer">

<strong>摘要</strong>: Breaking News: The FDA is planning to warn that the Johnson  Johnson coronavirus vaccine can increase the risk of a rare nerve condition known as Guillain-Barré syndrome. https://t.co/HP3GFKFzsGmdash; The New York Times (@nytimes) July 12, 2021拟《路透社》报道，《华盛顿邮报》周一(12日)引述4名知情人士，美国食品和药物管理局(FDA)将就强生公司的新型冠状病毒疫苗发出新警告，该疫苗与一种罕见的自身免疫性疾病有关。据报导，FDA准备对强生(JNJ.N)新冠疫苗发布新的警告，因该疫苗与引发格林－巴利症候群有关 (GBS) 。 GBS是一种免疫系统攻击神经而产生的一种严重但罕见的副作用。美国疾病控制及预防中心在一份 ... <span class="more"><img width="35" src="https://www.kuai.media/news/2021/07/13/static/image/kuai/external-link.gif" referrerpolicy="no-referrer">点击阅读全文 @wenxuecity.com</span>
</a>


  
</div>
            